Antibody-drug conjugate may inhibit pancreatic cancer.
出版信息
Cancer Discov. 2013 Dec;3(12):OF1. doi: 10.1158/2159-8290.CD-NB2013-160. Epub 2013 Nov 7.
Abstract
摘要
相似文献
1
Antibody-drug conjugate may inhibit pancreatic cancer.抗体药物偶联物可能抑制胰腺癌。
Cancer Discov. 2013 Dec;3(12):OF1. doi: 10.1158/2159-8290.CD-NB2013-160. Epub 2013 Nov 7.
2
Bevacizumab proves active in wide range of cancers.
Oncology (Williston Park). 2004 Aug;18(9):1158, 1199.
3
New agents in colon cancer.结肠癌的新型药物
Clin Adv Hematol Oncol. 2003 Jul;1(7):404-5.
4
Current status of chemotherapy in metastatic pancreatic cancer.转移性胰腺癌化疗的现状
Anticancer Res. 1989 Jul-Aug;9(4):1027-31.
5
New approaches tackle rising pancreatic cancer rates.新方法应对胰腺癌发病率上升问题。
J Natl Cancer Inst. 2014 Dec 22;106(12). doi: 10.1093/jnci/dju417. Print 2014 Dec.
6
Trastuzumab faces trials, clinical and otherwise.曲妥珠单抗面临着各种试验，包括临床试验及其他方面的试验。
J Natl Cancer Inst. 2006 Mar 1;98(5):296-8. doi: 10.1093/jnci/djj110.
7
[Problems of antineoplastic chemotherapy of pancreatic cancer].[胰腺癌的抗肿瘤化疗问题]
Zentralbl Chir. 1987;112(21):1322-36.
8
A review of kinases implicated in pancreatic cancer.一篇综述涉及到参与胰腺癌的激酶。
Pancreatology. 2009;9(6):738-54. doi: 10.1159/000199435. Epub 2010 Jan 15.
9
Novel agents in the treatment of pancreatic adenocarcinoma.胰腺癌治疗中的新型药物
JOP. 2013 Mar 10;14(2):138-40. doi: 10.6092/1590-8577/1474.
10
Rituximab.利妥昔单抗
Cancer Chemother Biol Response Modif. 2003;21:235-58.
Zotero 插件